Pharmacological effects Mechanism of Action Adverse Drug Reactions
ChemicalBook > CAS DataBase List > Terlipressin acetate

Terlipressin acetate

Pharmacological effects Mechanism of Action Adverse Drug Reactions
Terlipressin acetate Structure
Terlipressin acetate
  • CAS No.14636-12-5
  • Chemical Name:Terlipressin acetate
  • CBNumber:CB4266213
  • Molecular Formula:C52H74N16O15S2
  • Formula Weight:1227.37
  • MOL File:14636-12-5.mol
Terlipressin acetate Property
  • Melting point >170°C (dec.)
  • Boiling point 1824.0±65.0 °C(Predicted)
  • Density 1.46±0.1 g/cm3(Predicted)
  • storage temp. Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
  • solubility DMSO (Slightly), Methanol (Slightly)
  • form Solid
  • pka 9.90±0.15(Predicted)
  • color White
  • Sequence Gly-Gly-Gly-c[Cys-Tyr-Phe-Gln-Asn-Cys]-Pro-Lys-Gly-NH2,(Disulfide bridge: Cys-Cys)
  • InChIKey BENFXAYNYRLAIU-ITQMCZIINA-N
  • CAS DataBase Reference 14636-12-5(CAS DataBase Reference)
  • FDA UNII 7Z5X49W53P
  • NCI Drug Dictionary terlipressin
  • ATC code H01BA04
Safety
  • HS Code  :3504009000
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal wordWarning
  • Hazard statements H332
  • Precautionary statements P261-P271-P304+P340-P312

Terlipressin acetate Chemical Properties,Usage,Production

  • Pharmacological effects Terlipressin acetate is a novel long-acting synthetic vasopressin reagent,its chemical name is three glycyl lysine vasopressin, it is a prodrug, itself has no activity ,in vivo  , it removes three glycyl residues in its N-terminus by aminopeptidase, and slowly "releases" the active lysine vasopressin. It is this "slow release" mechanism that makes it maintain the smooth muscle contraction up to 10 hours after a single administration, whereas the same dose of vasopressin, it can maintain its activity for 20-40 minutes. On the other hand,because of the slow digestion,  lysine vasopressin in the circulation cannot reach toxic levels, and usage of  terlipressin is safer.Pharmacological effect of terlipressin is splanchnic vascular smooth muscle contraction, and reduction of visceral blood flow (such as reducing blood flow in the mesentery, spleen, uterus, etc.), thereby reducing portal vein blood flow,and reducing portal pressure, on the other hand it may also reduce plasma renin concentration, thereby increasing the renal blood flow in patients with hepatorenal syndrome, to improve kidney function, and increase urine output. Terlipressin is currently the only drug which is able to increase mortality in patients with esophageal varices bleeding , it is previously mainly used in clinical for the treatment of variceal bleeding, in addition,terlipressin now has also been successfully used for liver and kidney integrated syndrome and refractory shock, it is also likely to play a useful role in the cardiopulmonary resuscitation . Compared with vasopressin, it has a lasting effect, and it does not cause dangerous complications, including promoting  fibrinolysis and severe complications in the cardiovascular systems, and the use of it is simple (available intravenous injection), it is more suitable for rescue and treatment of emergent and critical  patients.
  • Mechanism of Action Terlipressin acetate, a synthetic triglycyl-lysine derivative of vasopressin, is a inactive prodrug. It has pressor and antidiuretic effects. Following IV injection, lysine vasopressin are released following the enzymatic cleavage of 3 glycyl moieties.Duration: 4-6 hr.
  • Adverse Drug Reactions Abdominal cramps, cardiac arrhythmias, headache, transient blanching, increased arterial pressure.
    Potentially Fatal: MI, cardiac failure.
  • Description Terlipressin acetate is a novel synthetic long-acting vasopressin preparation. It is a kind of prodrug, which is inactive by itself. After the action of aminopeptidase in the body, after removing the three glycyl residues at its N-terminus, it slowly "releases" the active lysine vasopressin. Therefore, terlipressin acts as a reservoir that releases lysine vasopressin at a steady rate.
  • Chemical Properties N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin (Terlipressin acetate) is White Solid
  • Uses Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It is used norepinephrine-resistant septic shock and hepatorenal syndrome. It is also used in the treatment of acute variceal bleeding. Terlipressin Acetate 1 mg solution for injection is used for the treatment of: bleeding from dilated (widening) veins in the food pipe leading to your stomach (called bleeding oesophageal varices).
  • Definition ChEBI: Terlipressin is a polypeptide.
  • Clinical Use Treatment of bleeding oesophageal varices
  • Side effects In clinical trials, the most common side effects of terlipressin administration were paleness, increased blood pressure, peripheral ischemia, abdominal pain, nausea, diarrhea, and headache.
    Terlipressin related adverse events are common and most of terlipressin related adverse events were mild or moderate, which can be resolved spontaneously without any intervention. As terlipressin acts mainly on the splanchnic vessels, the incidence of severe ischemic complications is lower with terlipressin than with vasopressin. However, it may cause serious complications such as myocardial infarction, intestinal ischemia, peripheral cyanosis, and skin necrosis[1].
  • Metabolism Terlipressin is metabolised by tissue peptidases resulting in the slow release of lypressin. Terlipressin is almost completely metabolised in the kidneys and liver, with less than 1% of terlipressin and less than 0.1% of lypressin excreted in the urine.
  • References [1] Chiang C, et al. Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome. American Journal of Case Reports, 2019.
Terlipressin acetate Preparation Products And Raw materials
Raw materials
Preparation Products
Global(415)Suppliers
  • Supplier:
    Cellmano Biotech Limited
  • Tel:0551-65326643<br/>18156095617
  • Email:info@cellmano.com
  • Country:China
  • ProdList:995
  • Advantage:58
  • Supplier:
    Apextide Co Ltd
  • Tel:+86-15300650552<br/>+86-15300650552
  • Email:info@apextide.com
  • Country:China
  • ProdList:92
  • Advantage:58
  • Supplier:
    RongNa Biotechnology Co.,Ltd
  • Tel:+86-86-13583358881<br/>+8618560316533
  • Email:Brad@rongnabiotech.com
  • Country:China
  • ProdList:3084
  • Advantage:58
  • Supplier:
    henan kanbei chemical co.,ltd
  • Tel:+undefined-86-1523780-4566<br/>+undefined15237804566
  • Email:henankanbeichemical@163.com
  • Country:China
  • ProdList:511
  • Advantage:58
Terlipressin acetate Spectrum
14636-12-5, Terlipressin acetateRelated Search:
  • 14636-12-5
  • Amino Acid Derivatives
  • Peptide
  • hormones
  • 药用肽
  • 杂质对照品
  • 抑制剂
  • 生化试剂
  • 国内外备案原料药
  • 药物多肽系列
  • 化学试剂
  • 环肽
  • 柏锦生物
  • 医药体
  • 武汉贝尔卡主打
  • 贝尔卡主打
  • 医药原料
  • 化工中间体
  • 化学产品
  • 特利加压素
  • 肽类
  • 药物肽
  • 药物多肽
  • 对照品-中药对照品
  • 医用原料
  • 原料中间体-原料药
  • 多肽原料药
  • 生物制药
  • 多肽中间体
  • 原料药
  • 原料药(API)
  • 中间体
  • 蛋白质/多肽
  • 多肽
  • 医药原料药
  • C52H74N16O15S2C2H4O2
  • C52H74N16O15S2
  • 156-1-3
  • 146363-12-5
  • THYMOSIN Α1 ACETATE 醋酸胸腺肽Α1
  • TERLIPRESSIN ACETATE 醋酸特利加压素
  • 1-三甘氨酰-8-赖氨酸 加压素
  • 特利加压素醋酸盐
  • 特利加压素用于NMR鉴定
  • 特利加压素醋酸酯盐
  • 特利加压素?, >99%
  • 特利加压素-多肽制剂一致性评价
  • 特利加压素-多肽原料委托生产
  • 利加压素
  • 醋酸特利加压素 TERLIPRESSINACETATE
  • 醋酸特利加压素 14636-12-5
  • 酸特利加压素
  • 醋酸胸腺肽AL
  • 特利加压素
  • 醋酸特利加压素
  • 14636-12-5
  • Terlipressin for NMR identification
  • TERLIPRESSIN